chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history were reported.     On 03-Apr-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medication reported.  Treatment information not provided
Two days later I had intense squeezing in my chest only randomly through the day. By the weekend I couldn?t even raise my arms and had really bad chest pain and directly behind in my back . I felt very tired and week for about a week with constant heaviness and squeezing in the chest and breast area . It is getting better but I still wake up with it.
POST VACCINE, FELT DIZZY, HOT, NAUSEA, LIKE SHE WAS GOING TO PASS OUT. BROUGHT TO OBS VIA WC. PLACED IN TRENDELENBERG ON STRETCHER, STATES RELIEF OF SYMPTOMS AFTER A FEW MINUTES, VSS THROUGHOUT OBSERVATION OF LYING TO STANDING. ESCORTED TO EXIT TO MEET FATHER WHO DROVE AT 1320 WITH NO ISSUES.  1250 INITIAL BP 109/67 HR 66 RR 16 SATS 99% RA 1255 113/65 HR 65 RR 18 SATS 100% RA 1256 SITTING BP 118/72 HR 76 RR 16 SATS 98% RA 1257 STANDING BP 117/73 HR 76 RR 16 SATS 98% RA
COVID-19 SYMPTOMS; STUFFY HEAD; STUFFY NOSE; SNEEZING; This spontaneous report received from a patient concerned a 36 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808980 expiry: 15-FEB-2022) dose was not reported, administered on 07-APR-2021 for covid-19 prophylaxis. Age at time of vaccination 36 years old. No concomitant medications were reported. On 01-AUG-2022, the patient experienced stuffy head, stuffy nose, and sneezing. On an unspecified date, the patient experienced covid-19 symptoms. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the covid-19 infection, stuffy head, stuffy nose and sneezing was not reported. This report was non-serious.
Redness, warmth and swelling at injection site. Patient has experienced this with previous covid immunizations
After first shot - exhausted 24 hrs - per donor/friends.  s/s that occurred after this shot: dizzy/nausea/pale/faint feeling/weakness.  Elevated legs, monitored vs, 10 oz H2O and 5 oz yogurt given.
On 08/11/2022 I started feeling facial weakness and having a hard time closing my left eye. I was diagnosed with Bells Palsy. About a week later on 8/18/2022 I woke up and had weakness in my legs, face and off balance. I went to the ER and was admitted after they confirmed that it was a stroke. I was prescribed Coditel and advised to stop taking Baby Aspirin. I was discharged after 4 nights.
Patient presented to the clinic for typhoid injection due to traveling to Africa in 3 weeks. Patient denies any adverse reactions to vaccines in the past or fainting or passing out after receiving a vaccine in the past. VIS provided. Patient left clinic without incident, Patient continued to go shopping for probiotics in the store about 20 min later her husband knocked on the clinic door stating my wife feels like she is going to pass out. Found patient laying awake , alert and oriented on the floor. Patient and husband denied any LOC patient stated she felt very weak and dizzy husband helped lower her to the floor and denied any falls or bumping her head. PAtient stated she felt very weak, dizzy , hot / cold also described a tight sensation in her nasal passages. Denied any SOB , CP , throat tightness no signs of swelling or rash noted. NP continued to st ay with patient and instructed husbands to get juice, water, and a granola bar (pt only had breakfast in the AM and a few snacks around 11 am did not have lunch yet,  patient VS were 110/78 , 99% o2 sat, hr 75 and temp 97.8  RR 20 , after 20 min attempted to get patient to stand patient stood up but felt very dizzy a chair was taken from pharmacy and placed behind her was assisted with husband in the chair patient continued to have the above symptoms despite 45 min time elapsing discussed and agreed to call 911 for further evaluation, Ambulance staff and police arrived around 2:15 pm - blood sugar was evaluated was 135 patient and husband agreed to go to the Valley ER via ambukance for further assessment and evaluation transported around 2:40 pm
Patient complained of swelling and pain at the injection site a few days after administration. She also complained of prolonged pain in her left upper arm continuing through today.
Left arm local reaction; pain, redness - 5 cm x 5 cm circular rash.
Pt. states that her arm from the elbow down started to tingle. Her hand feels like it has "fallen asleep". When asked about redness, swelling, or tenderness at the site of the vaccination, patient states there is "a little" but not a lot. Pt. has spoken to MD about symptoms. Advised to seek MD attention with PCP or ER if symptoms persists.
Information has been received from the father of a 19 month old male with no medical history and no known allergies who on 10-NOV-2007 was vaccinated with a dose of PedvaxHIB (Lot# 656519/0259U). On 27-NOV-2007, 17 days post vaccination the patient experienced a stiff neck, high fever and developed rashes all over his body. The patient was admitted to the hospital for one day but the physicians did not determine what caused the sickness. On 28-NOV-2007 the patient was discharged from the hospital. At the time of this report, the patient was recovering. No product quality complaint was involved. Additional information has been requested.  12/28/07 Reviewed hospital ER medical records of 12/05/2007 which reveal patient experienced fever & irritability x 2 days.  Saw pcp who found patient unable to extend neck.  Sent to ER to r/o retropharyngeal abscess due to tonsillar & oropharynx erythema.    Tx w/oral antibiotics. FINAL ER DX: fever & otitis media.
Systemic: Dizziness / Lightheadness-Severe, Systemic: Hypotension-Mild, Systemic: Shakiness-Mild, Systemic: Weakness-Medium
After client received 1st dose of Pfizer in left deltoid, client stood up to receive vaccine card and ID. Client then passed out, fell on the floor and hit head. C/O right side jaw hurts. MD & EMT evaluated. 130/75, 75, 97%, zero bumps felt on head/scalp. Girlfriend at side, instructed to go to ER to be evaluated today.
I developed a fever in the evening of the day I received my 2nd dose.  I took some ibuprofen, and felt better about 10pm and went to bed.  I awoke feeling nauseous about 1 am and walked to the bathroom.  I passed out in the hallway and hit my head.  I'm not sure how long I was unconscious, but I awoke with a bleeding head.  The next day I went to urgent care for evaluation.  They did an EKG, IV fluids, CBC, comp metabolic panel, D-Dimer test.  The following day, my neck gave me so much pain, that I needed to go back to urgent care.  They did a head and neck CT and prescribed Tizanidine.  This medication did not help the pain subside, and it necessitated a trip to the ER the following day.  There, I was prescribed diazepam, which helped.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (itchy from head to toe) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. No Medical History information was reported. On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 21-Apr-2021, the patient experienced PRURITUS (itchy from head to toe). At the time of the report, PRURITUS (itchy from head to toe) outcome was unknown. The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown. Concomitant product use was not provided. Treatment information was not provided. Most recent FOLLOW-UP information incorporated above includes: On 21-Apr-2021: Significant Follow up received on 21-4-2021, patient information added, drug information added.
I received the Tdap vaccine while in the hospital recovering from giving birth. At first my arm was sore, which I had expected from that particular shot. My husband got the same shot, but a few days later at a pharmacy.  The pain seemed to be getting worse and my husband?s pain subsided before mine, which was when I first started noticing something wasn?t right. The pain was in my upper shoulder where she had given the injection. It got to the point where I could barely pick up and hold my newborn and I couldn?t sleep at night without being in a lot of pain no matter how I slept. My mother is a physical therapy assistant so I asked her about it and she gave me some exercises to try. They helped a little, but the pain was still pretty intense. I?m not exactly sure how long the pain lasted, but it was probably a couple months or so.  It has finally subsided and doesn?t bother me anymore.  I did some reading and realized that this could be an adverse reaction from the vaccine being injected too high. My husband?s shot location was indeed lower than mine.
Patient was given the vaccine 3 days past the expiration. His mother called his provider on 4/26 for a rash that was on his leg and groin that she thought was due to the vaccine. He did not have any other symptoms so was not scheduled to come in until the next day, but his mother was concerned and mentioned she would likely take him to the ED that day. No other encounters have been made regarding this rash, but the provider does not think it was due to the vaccine given the time frame.
This is a spontaneous report from contactable consumer (patient) from a Pfizer sponsored program support. A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: UNKNOWN), via an unspecified route on 21May2021 as a SINGLE DOSE for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On unspecified date in May 2021, after her shot, her arm really hurts. The outcome of the event was unknown. Information on the lot/batch number has been requested.
Initial report received from health care professional on 19 Feb 2010. This child was vaccinated with Fluvirin of an unknown batch number on 19 Dec 2009, intramuscularly. On 02 Jan 2010, the patient experienced rash. On 07 Feb 2010, the patient began experiencing abdominal pain. On 17 Feb 2010, the patient went to the doctor's office and was diagnosed with Henoch-Schonlein purpura (HSP). The patient's platelets were normal. The outcome of the event was not reported.
Had hives for going on 3 months now; This spontaneous case was reported by a consumer and describes the occurrence of URTICARIA (Had hives for going on 3 months now) in a 48-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027L20A and 031120A) for COVID-19 vaccination.     No Medical History information was reported.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 12-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. In February 2022, the patient experienced URTICARIA (Had hives for going on 3 months now). At the time of the report, URTICARIA (Had hives for going on 3 months now) had not resolved. No concomitant medications were provided. Patient reported his experiences after receiving 2 primary doses (2nd dose lot number 027L20A on 12Mar2021) of the Moderna Covid-19 Vaccine. The patient has had hives for going on 3 months at the time of report. No treatment medications were reported.
This spontaneous report as received from a health professional refers to a 17 year old patient of unknown gender. There was no information about the patient's concurrent conditions, concomitant therapies or medical history provided. On 30-NOV-2015, the patient was vaccinated with an improperly stored dose of VARIVAX lot # L024256, expiration date: 01-JUL-2017 (exact dose and route of administration were not reported). There was no adverse effect reported. Administered dose of vaccine experienced the temperature excursion of 20.3 degrees Fahrenheit for 72 hours. Data logger was involved. There were no previous excursions reported. This is one of several reports received from the same reporter. Additional information has been requested.
My Urine had blood in it for a day and was very painful.  The next day the blood stopped and the pain has greatly decreased
Urticarial rash with patches of angioedema onset 3/28/2019 required treatment 3/31/2019 with Prednisone and BENADRYL, with duration of urticarial rash until 4/10/2019 with slow resolution on prednisone taper down to 5 mg daily. Location neck, anterior chest and breast, abdomen, waistline, gluteal and anterior thighs. No respiratory symptoms and no mucous membrane involvement.
This case was reported by a pharmacist via call center representative and described the occurrence of itchy rash in a elderly female patient who received SHINGRIX (batch number 27K24, expiry date 2nd February 2021) for prophylaxis. On an unknown date, the patient received the 1st dose of SHINGRIX. On an unknown date, less than a year after receiving SHINGRIX, the patient experienced itchy rash. On an unknown date, the outcome of the itchy rash was recovered/resolved. It was unknown if the reporter considered the itchy rash to be related to SHINGRIX. Additional details were provided as follows: The age at vaccination was not reported. The patient experienced a rash and itching on her stomach which lasted 2 days. The healthcare professional (HCP) not comfortable providing patient initials.
The patient had an unspecified "tick bite" on the same arm of vaccination; The patient experienced hives on unspecified areas of the body; This spontaneous report was received from a physician via company representative and referring to a female patient of an age reported between 11 or 13 years old. There was no information provided about the patient's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or medical history.  On 08-JUL-2019, the patient was vaccinated with the first dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9), intramuscularly for prevention of human papillomavirus (HPV) (strength, dosage schedule, lot number and expiration date were not reported).  On the same date, the patient developed hives (urticaria) on different areas of her body, it was also reported that the patient had an unspecified "tick bite" (arthropod bite) on the same vaccinated arm. It was reported that the patient sough for medical attention and received treatment (unspecified) for urticaria. The outcome of the aforementioned events was unknown at the reporting time.    Furthermore, it was unknown by the reporter if any laboratory diagnostic or studies were performed.   The causal relationship between hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast)(GARDASIL 9) and the events was not reported.
4th dose Pediarix; This case was reported by a other health professional via call center representative and described the occurrence of extra dose administered in a 15-month-old male patient who received DTPa-HBV-IPV (Pediarix) (batch number 9X3TS, expiry date unknown) for prophylaxis.   Co-suspect products included dtpa-hbv-ipv vaccine pre-filled syringe device (Pediarix Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Pediarix (received 3 doses on an unknown date).   On 22nd June 2022, the patient received the 4th dose of Pediarix and Pediarix Pre-Filled Syringe Device. On 22nd June 2022, unknown after receiving Pediarix and Pediarix Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK Receipt Date: 24-JUN-2022 Reporter's Comments:  The reporter was medical assistant at health care professional office who called in to report that a patient received a 4th dose of Pediarix. The patient had already received his 3 doses and completed the series but accidentally received a 4th dose. Initials of patient unavailable during call. The vaccine administration facility was the same as primary reporter The reporter consented to follow up. Additional Supportive Information: The patient received a 4th dose of Pediarix, which led to extra dose administered.
after second does I have had a racing heart and shortness of breath.; after second does I have had a racing heart and shortness of breath.; This is a spontaneous report from a contactable consumer (Patient) via Regulatory Authority.   A 54-year-old female patient (non-pregnant) received bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EWO170), via an unspecified route of administration, administered in left arm on 24Apr2021 at 12pm (at the age of 54-year-old) for COVID-19 immunisation at Pharmacy or Drug Store. The patient medical history and concomitant medications were not reported. The patient did not received any other vaccine in four weeks and received other medications in two weeks. The patient was not diagnosed with covid prior to vaccination and not been tested for covid post vaccination. No known allergies. The patient medical history reported as none. Historical Vaccine include bnt162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: ER8737), via an unspecified route of administration, administered in right arm on 02Apr2021 at 13:15 for COVID-19 immunisation and experienced extreme pain in opposite armpit of vaccine site. On an unknown date in May2021, the patient had a racing heart and shortness of breath. Treatment received for the event was unknown. The reporter further stated that today (on the day of this report) was 10 days after and her gym workout was extremely hard due to shortness of breath. Patient stated she was fit and this was not normal. The clinical outcome of both the events was not recovered.  No follow up attempts are possible. No further information is expected
This case was reported by a pharmacist via call center representative and described the occurrence of injection site pain in a male patient who received KINRIX. On an unknown date, the patient received KINRIX (subcutaneous). On an unknown date, unknown after receiving KINRIX, the patient experienced injection site pain and intramuscular formulation administered by other route. On an unknown date, the outcome of the injection site pain and intramuscular formulation administered by other route were unknown. It was unknown if the reporter considered the injection site pain to be related to KINRIX. Additional details were provided as follows: The age at vaccination was not reported. The reporter was a pharmacist who reported event for her son. The patient received KINRIX subcutaneously, which led to inappropriate route of administration. The area where injection occurred hurt the patient a lot. The reporter declined to provide demographics and declined to proceed with safety report.
Near syncopal x 3, pale, diaphoretic, vomiting x 1. No respiratory distress/ hives/ swelling/ fever.
Information has been received from a physician concerning a 67 year old female who on 31 Oct 2006 was vaccinated with a 0.65ml dose of varicella zoster virus vaccine live. On 03 Nov 2006, the patient developed a rash and blisters that follow the dermatone and also experienced pain. Unspecified medical attention was sought. A product quality complaint was not involved. Additional information has been requested.
Information has been received from a physician concerning a female in her 60's who was vaccinated with Zostavax (Oka/Merck) for the treatment of shingles.  Subsequently the patient experienced induration.  Subsequently, the patient recovered from induration.  Additional information has been requested.
Injection site has been hurting; Pain; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Injection site has been hurting) and PAIN (Pain) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LOSARTAN for an unknown indication.    On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Mar-2021, the patient experienced VACCINATION SITE PAIN (Injection site has been hurting) and PAIN (Pain). At the time of the report, VACCINATION SITE PAIN (Injection site has been hurting) and PAIN (Pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient's medical history was not provided.  Concomitant product use was Cholesterol medicine. No treatment medication was reported.